Consulting Services for Medical and Scientific Technologies
1.877.397.8980EMAIL


MDxI uses proficiency testing data along with other data sources to deliver comprehensive IVD tracking reports that cover more than 500 analytes across 10 laboratory testing disciplines. The Clinical Laboratory Improvement Amendments of 1988 (CLIA) require all labs to participate in an ongoing, certified PT program, and nearly all hospital and commercial reference laboratories participate. Reports are issued to subscribers twice a year.

These reports cover more than 500 analytes in 10 scientific disciplines:
  • Overview +

  • Chemistry +

    The IVD Insights™ Chemistry Market Tracking Report provides a near-census overview of the US clinical chemistry and urine toxicology markets, covering 64 analytes performed by 4,675 laboratories on 10,823 instrument systems. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      SITES INSTRUMENTS
    TOTAL 4,895 21,760
         
    Short-Term Acute Care Hospitals 3,205 16,891
    - University 153 1,419
    - Community Teaching 934 6,100
    - Community Non-Teaching 1,643 7,141
    - Military/VA 148 1,357
    - Critical Access 327 874
         
    Independent Commercial Laboratories 450 2,149
    - <250K tests per year 110 273
    - 250K – 1M tests per year 95 358
    - 1M – 2.5M tests per year 65 314
    - 2.5M – 4M tests per year 23 116
    - 4M – 10M tests per year 54 409
    - 10M+ tests per year 54 522
         
    Clinics/POLs 1,135 2,553
         
    Other 105 167
    - Long-Term Care/Rehab Hospitals 63 104
    - Public Health Laboratories 23 44
    - Blood Bank Laboratories 19 19
  • Immunochemistry +

    The IVD Insights™ Immunochemistry Market Tracking Report provides a near-census overview of the US immunochemistry market, covering 129 analytes. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      SITES INSTRUMENTS
    TOTAL 5,149 21,876
         
    Short-Term Acute Care Hospitals 3,264 17,249
    - University 153 1,393
    - Community Teaching 950 6,101
    - Community Non-Teaching 1,672 7,435
    - Military/VA 147 1,224
    - Critical Access 342 1,096
         
    Independent Commercial Laboratories 486 1,990
    - <250K tests per year 122 268
    - 250K – 1M tests per year 103 329
    - 1M – 2.5M tests per year 68 287
    - 2.5M – 4M tests per year 27 105
    - 4M – 10M tests per year 58 378
    - 10M+ tests per year 57 491
         
    Clinics/POLs 1,298 2,489
         
    Other 101 148
    - Long-Term Care/Rehab Hospitals 72 104
    - Public Health Laboratories 25 40
    - Blood Bank Laboratories 4 4
  • Hematology +

    The IVD Insights™ Hematology Market Tracking Report provides a near-census overview of the US hematology market, covering 20 analytes. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      SITES INSTRUMENTS
    TOTAL 4,977 9,085
         
    Short-Term Acute Care Hospitals 3,070 6,495
    - University 148 468
    - Community Teaching 905 2,135
    - Community Non-Teaching 1,550 3,105
    - Military/VA 147 342
    - Critical Access 320 445
         
    Independent Commercial Laboratories 419 652
    - <250K tests per year 120 143
    - 250K – 1M tests per year 85 122
    - 1M – 2.5M tests per year 57 104
    - 2.5M – 4M tests per year 19 40
    - 4M – 10M tests per year 45 96
    - 10M+ tests per year 51 87
         
    Clinics/POLs 1,270 1,635
         
    Other 218 303
    - Long-Term Care/Rehab Hospitals 111 142
    - Public Health Laboratories 16 19
    - Blood Bank Laboratories 91 142
  • Coagulation +

    The IVD Insights™ Coagulation Market Tracking Report provides a near-census overview of the US coagulation market, covering 48 analytes. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      SITES INSTRUMENTS
    TOTAL 5,546 12,583
         
    Short-Term Acute Care Hospitals 4,529 10,840
    - University 456 758
    - Community Teaching 1,564 3,673
    - Community Non-Teaching 2,098 5,092
    - Military/VA 74 669
    - Critical Access 337 648
         
    Independent Commercial Laboratories 424 708
    - <250K tests per year 90 166
    - 250K – 1M tests per year 81 132
    - 1M – 2.5M tests per year 45 86
    - 2.5M – 4M tests per year 18 25
    - 4M – 10M tests per year 80 113
    - 10M+ tests per year 75 125
         
    Clinics/POLs 527 941
         
    Other 66 94
    - Long-Term Care/Rehab Hospitals 53 75
    - Public Health Laboratories 6 7
    - Blood Bank Laboratories 7 12
  • Autoimmune Disease +

    The IVD Insights™ Autoimmune Disease Market Tracking Report provides a near-census overview of the US autoimmune disease market, covering 81 analytes. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      SITES INSTRUMENTS
    TOTAL 2,468 1,953
         
    Short-Term Acute Care Hospitals 1,902 1,319
    - University 113 148
    - Community Teaching 645 650
    - Community Non-Teaching 917 412
    - Military/VA 120 100
    - Critical Access 107 9
         
    Independent Commercial Laboratories 248 464
    - <250K tests per year 26 24
    - 250K – 1M tests per year 48 59
    - 1M – 2.5M tests per year 43 72
    - 2.5M – 4M tests per year 20 29
    - 4M – 10M tests per year 47 102
    - 10M+ tests per year 46 151
         
    Clinics/POLs 294 161
         
    Other 24 9
    - Long-Term Care/Rehab Hospitals 17 8
    - Public Health Laboratories 5 1
    - Blood Bank Laboratories 2 0
  • Infectious Immunology +

    The IVD Insights™ Infectious Immunology Market Tracking Report provides a near-census overview of the US infectious immunology market, covering 37 analytes. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics and long-term care/rehabilitation.
      SITES INSTRUMENTS
    TOTAL 3,875 7,942
         
    Short-Term Acute Care Hospitals 2,768 6,310
    - University 134 576
    - Community Teaching 840 2,510
    - Community Non-Teaching 1,424 2,550
    - Military/VA 128 469
    - Critical Access 242 205
         
    Independent Commercial Laboratories 357 990
    - <250K tests per year 69 59
    - 250K – 1M tests per year 78 143
    - 1M – 2.5M tests per year 53 140
    - 2.5M – 4M tests per year 19 57
    - 4M – 10M tests per year 52 214
    - 10M+ tests per year 50 306
         
    Clinics/POLs 539 458
         
    Other 211 184
    - Long-Term Care/Rehab Hospitals 62 42
    - Public Health Laboratories 101 50
    - Blood Bank Laboratories 48 92
  • Immunohematology +

    The IVD Insights™ Immunohematology Market Tracking Report provides a near-census overview of the US immunohematology market, covering 6 analytes. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics and long-term care/rehabilitation.
  • Microbiology +

    The IVD Insights™ Microbiology Market Tracking Report provides a near-census overview of the US microbiology market, covering 2,790 sites performing 31 analytes on 5,500 instrument systems. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      SITES INSTRUMENTS
    TOTAL 4,022 3,361
         
    Short-Term Acute Care Hospitals 2,978 2,922
    - University 137 149
    - Community Teaching 877 950
    - Community Non-Teaching 1,544 1,452
    - Military/VA 139 200
    - Critical Access 281 171
         
    Independent Commercial Laboratories 269 253
    - <250K tests per year 46 14
    - 250K – 1M tests per year 47 27
    - 1M – 2.5M tests per year 42 38
    - 2.5M – 4M tests per year 20 20
    - 4M – 10M tests per year 47 63
    - 10M+ tests per year 46 79
         
    Clinics/POLs 607 140
         
    Other 168 46
    - Long-Term Care/Rehab Hospitals/Other Facilities 65 29
    - Public Health Laboratories 99 14
    - Blood Bank Laboratories 4 3
  • Molecular Infectious Disease +

    The IVD Insights™ Molecular Infectious Disease Market Tracking Report provides a near-census overview of the US molecular infectious disease testing market, covering 39 analytes performed by 2,476 laboratories on 4,267 instrument systems. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      MOLECULAR SITES MOLECULAR INSTRUMENTS
    TOTAL 2,074 3,846
         
    Short-Term Acute Care Hospitals 1,432 2,570
    - University 100 371
    - Community Teaching 583 1,129
    - Community Non-Teaching 590 768
    - Military/VA 122 269
    - Critical Access 37 33
         
    Independent Commercial Laboratories 303 812
    - <250K tests per year 73 105
    - 250K – 1M tests per year 49 98
    - 1M – 2.5M tests per year 42 120
    - 2.5M – 4M tests per year 23 58
    - 4M – 10M tests per year 46 181
    - 10M+ tests per year 45 207
         
    Clinics/POLs 165 202
         
    Other 174 262
    - Long-Term Care/Rehab Hospitals 36 43
    - Public Health Laboratories 100 138
    - Blood Bank Laboratories 38 81
  • Molecular Genetics +

    The IVD Insights™ Molecular Genetics Market Tracking Report provides provides a near-census overview of the US molecular genetics market, covering 44 analytes performed by 1,098 (including HER2) and 332 laboratories (excluding HER2). Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics, and long-term care/rehabilitation facilities.
      SITES SITES
      Including HER2 Excluding HER2
    TOTAL 1,198 546
         
    Short-Term Acute Care Hospitals 852 304
    - University 94 78
    - Community Teaching 401 167
    - Community Non-Teaching 333 40
    - Military/VA 22 19
    - Critical Access 2 0
         
    Independent Commercial Laboratories 269 188
    - <250K tests per year 105 62
    - 250K – 1M tests per year 37 27
    - 1M – 2.5M tests per year 34 24
    - 2.5M – 4M tests per year 9 6
    - 4M – 10M tests per year 35 31
    - 10M+ tests per year 18 14
         
    Clinics/POLs 52 30
         
    Other 25 24
    - Long-Term Care/Rehab Hospitals 18 17
    - Public Health Laboratories 5 5
    - Blood Bank Laboratories 2 2
  • 1
Every Market Tracking Report includes information on:
  • Each manufacturer's share of systems, by model or methods used, for testing each analyte
  • Each manufacturer's share of sites using each system, by model or method, for testing each analyte
  • Average number of systems and/or methods used per site for testing each analyte
  • Total net number of sites in the database and the net total instruments in each relevant market segment, by manufacturer brand and model, with underlying share-shift dynamics
  • Share position change for sites and/or analytes compared to prior six months
  • Number of new systems placed, by brand and model, and/or methods adopted in the prior six months
  • Electronic data file of underlying raw data by site
The Market Tracking Reports segment information by:
  • Type of lab (hospital, reference, public health, clinic/physician office, blood donor, other)
  • Number of hospital beds
  • Annual CLIA testing volume
  • Optional custom segmentation of systems by throughput, specified client sales regions or territories, etc.
Custom reports are available that provide detail on instrument menu utilization, instrument portfolio segmentation, customized regional/sales territories, and other topics.

IVD Insights™ Reports

View All

IVD Insights™ LabFile

Get the most accurate market information specific to your needs.